GWM
BMY icon

Gitterman Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Gitterman Wealth Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-5,212
Closed -$241K – 155
2025
Q2 		$241K Buy
5,212
+46
+0.9% +$2.26K 0.06% 110
2025
Q1 		$315K Buy
+5,166
New +$301K 0.08% 72
2024
Q4 		– Sell
-4,449
Closed -$230K – 134
2024
Q3 		$230K Sell
4,449
-4,833
-52% -$227K 0.1% 94
2024
Q2 		$385K Buy
+9,282
New +$415K 0.15% 39
2022
Q3 		– Sell
-2,647
Closed -$203K – 73
2022
Q2 		$203K Buy
+2,647
New +$202K 0.19% 62

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gitterman Wealth Management's BMY Position: Q3 2025 in Review

Gitterman Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q3 2025, closing a stake of 5,212 shares — an estimated $241K sold.

Gitterman Wealth Management first reported a position in BMY in Q2 2022 and held it in 5 quarters. The position peaked at $385K in Q2 2024. 2,267 funds tracked by Wall St. Rank hold BMY as of Q3 2025.

  • Gitterman Wealth Management reported no remaining Bristol-Myers Squibb position as of Q3 2025 after selling out during the quarter.
  • Gitterman Wealth Management sold 5,212 Bristol-Myers Squibb shares in Q3 2025, an estimated $241K.
  • Gitterman Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2022 and held it in 5 quarters.
  • Gitterman Wealth Management's Bristol-Myers Squibb position peaked at $385K in Q2 2024.
  • 2,267 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2025.

Based on Gitterman Wealth Management's 13F filing for Q3 2025, filed 4 Nov 2025.